
Three years of specific immunotherapy may be sufficient in house dust mite respiratory allergy
Keywords: گرد و غبار خانه; Specific immunotherapy; duration; quality of life; asthma; rhinitis; house dust mite; clinical efficacy; compliance; children; immunotherapy relapses; AQLQ; Asthma Quality of Life Questionnaire; HDM; House dust mite; IT3; Patients receiving SIT for 3 year